Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» cancer
cancer
Cancer and diabetes drugs expected to dominate 2025 Medicare negotiations under IRA
BioSpace
Wed, 09/25/24 - 12:08 pm
Inflation Reduction Act
CMS
drug pricing
Pfizer
Merck
Bristol Myers Squibb
cancer
diabetes
Want better cancer treatments? Make biopharma more like Silicon Valley
BioPharma Dive
Wed, 09/25/24 - 11:53 am
cancer
biotech
oncology
Silicon Valley
Starton successfully delivers cancer drug using on-body injector
Clinical Trials Arena
Thu, 09/19/24 - 11:05 am
Starton Therapeutics
lenalidomide
cancer
drug delivery
on-body injector
How a radiopharma up-and-comer builds momentum in a surging space
Pharma Voice
Tue, 09/17/24 - 09:49 am
Ratio Therapeutics
radiopharmaceuticals
cancer
FDA approves Roche’s Tecentriq Hybreza for cancer
Yahoo Finance
Fri, 09/13/24 - 09:33 am
Roche
FDA
Tecentriq Hybreza
cancer
Gene therapy startup emerges with green light for first-of-its-kind trial
BioPharma Dive
Thu, 09/12/24 - 11:33 am
Vironexis
adeno-associated viruses
gene therapy
cancer
Bicara Therapeutics aims for up to $828 mln valuation in U.S. IPO
Reuters
Fri, 09/6/24 - 10:55 am
Bicara Therapeutics
IPOs
cancer
Novartis builds out radiopharma production with expansion, new factory
BioPharma Dive
Wed, 09/4/24 - 10:44 pm
Novartis
radiopharmaceuticals
Indianapolis
California
cancer
Bayer partners with NextRNA on lncRNA-targeted small molecules for cancer
First Word Pharma
Wed, 08/28/24 - 11:38 am
Bayer
NextRNA
IncRNAs
cancer
Illumina Gets FDA Approval for Cancer Biomarker Test
Marketwatch
Tue, 08/27/24 - 11:14 am
Illumina
FDA
Medtech
TruSight Oncology
cancer
diagnostics
Talus Bio tacks on $11M to target hard-to-reach transcription factors
Fierce Biotech
Tue, 08/20/24 - 11:39 am
Talus Bioscience
funding
transcription factors
cancer
drug discovery
Adcendo licenses Multitude anti-TF ADC in $1bn+ deal
Pharmaphorum
Tue, 08/20/24 - 10:27 am
Adcendo
antibody-drug conjugates
Multitude Therapeutics
cancer
anti-TF
Can BioNTech sustain a post-COVID mRNA pipeline? Oncology is the next hope.
Pharma Voice
Wed, 08/14/24 - 11:02 am
BioNTech
COVID-19
MRNA
oncology
cancer
Weight-loss drugs like Wegovy may help stave off some cancers
NPR
Mon, 08/12/24 - 11:28 am
cancer
GLP-1 agonist
Wegovy
Zepbound
Novo Nordisk
Eli Lilly
Roche considering divesting $1.9 bln cancer data startup, FT reports
Reuters
Wed, 08/7/24 - 11:24 am
Roche
Flatiron Health
cancer
oncology
io9’s AI cancer biomarker test outperforms NGS in new study data
Clinical Trials Arena
Mon, 08/5/24 - 11:14 am
io9
biomarkers
Medtech
diagnostics
artificial intelligence
OncoGaze
cancer
Vir Lays Off 25% of Staff, Abandons Most Virus Work and Pivots to Cancer in Sanofi Deal
BioSpace
Fri, 08/2/24 - 11:31 am
Vir Biotechnology
layoffs
Sanofi
cancer
virology
3 Big Pharma cancer drugs facing inflation penalties
Pharma Voice
Wed, 07/31/24 - 10:27 am
inflation
Inflation Reduction Act
drug pricing
Abecma
Breyanzi
Bristol Myers Squibb
Pfizer
Adcetris
Astellas
Padcev
cancer
Novartis hopes for better luck with bispecifics via $150M upfront Dren Bio deal
Fierce Biotech
Wed, 07/24/24 - 11:09 pm
Novartis
Dren Bio
cancer
bispecifics
Pharma aims to deliver personalized cancer therapies more quickly
Reuters
Wed, 07/24/24 - 11:48 am
cancer
oncology
drug development
personalized medicine
Pages
1
2
3
4
5
6
7
8
9
…
next ›
last »